A Study of the GRIP Influenza and SARS-CoV-2 POC Assays

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions
COVID-19Influenza
Interventions
DEVICE

GRIP Electronic Diagnostic Chip

Graphene-based point-of-care device for detection of respiratory viruses (e.g., COVID-19 and influenza) from a nasal swab

DIAGNOSTIC_TEST

Laboratory-based nucleic acid amplification tests (NAATs)

Polymerase Chain Reaction (PCR) analysis for detection of viruses (e.g., Roche cobas SARS-CoV-2 or influenza A/B) from nasal swab

Trial Locations (1)

55905

Mayo Clinic Minnesota, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

Mayo Clinic

OTHER

NCT05674370 - A Study of the GRIP Influenza and SARS-CoV-2 POC Assays | Biotech Hunter | Biotech Hunter